Search - tctmd.com

Displaying 61 - 80 of 242

Sort: Relevancy | Date

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

News Daily News

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

L.A. McKeown

June 01, 2022

News Daily News

SCAI-Led Position Statement on CLTI Spotlights Multispeciality Involvement

L.A. McKeown

April 27, 2022

News Conference News ACC 2022

Second-Generation Chocolate Touch DCB Bests Lutonix for Patency in PAD

L.A. McKeown

April 04, 2022

News Daily News

PAD Significantly Ups Morbidity and Mortality in AMICS

L.A. McKeown

March 29, 2022

News Daily News

Statins Underprescribed in PAD Before and After Interventions

L.A. McKeown

December 03, 2021

News Conference News VIVA 2021

Striking Racial Gaps Exist in Care for Peripheral Interventions, Registry Affirms

L.A. McKeown

October 07, 2021

News Conference News VIVA 2021

Vascular Care Falls Short Before Amputation for CLI: Medicare Analysis

L.A. McKeown

October 06, 2021

News Opinion CV Team Dispatch

September 2021 News Roundup

L.A. McKeown

September 01, 2021

News Daily News

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

L.A. McKeown

August 10, 2021

News Daily News

PAD Continues to Elude Clinicians, Despite Gains: AHA

L.A. McKeown

August 05, 2021

News Conference News ACC 2021

Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions

L.A. McKeown

May 21, 2021

News Conference News ACC 2021

SAFE-PAD Throws More Doubt on the Paclitaxel Mortality Signal

L.A. McKeown

May 16, 2021

News Daily News

Critical Limb Ischemia During COVID: Lessons for Care and Clinical Trials

L.A. McKeown

April 26, 2021

News Daily News

AHA Seeks to Drive Down Amputations 20% by 2030

L.A. McKeown

April 01, 2021

News Daily News

Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval

Michael O'Riordan

March 03, 2021

News Daily News

No Paclitaxel Death Signal in VA Data Out to 3 Years

L.A. McKeown

February 11, 2021

News Features

The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations

L.A. McKeown

December 24, 2020

News Daily News

‘Frailty Meter’ May Aid Treatment Decisions in Chronic Limb-Threatening Ischemia

L.A. McKeown

November 24, 2020

News Conference News VIVA 2020

BVS Reboot? Signs of Durability to 2 Years in Critical Limb-Threatening Ischemia

L.A. McKeown

November 11, 2020

Advertisement

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

SCAI-Led Position Statement on CLTI Spotlights Multispeciality Involvement

Second-Generation Chocolate Touch DCB Bests Lutonix for Patency in PAD

PAD Significantly Ups Morbidity and Mortality in AMICS

Statins Underprescribed in PAD Before and After Interventions

Striking Racial Gaps Exist in Care for Peripheral Interventions, Registry Affirms

Vascular Care Falls Short Before Amputation for CLI: Medicare Analysis

September 2021 News Roundup

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

PAD Continues to Elude Clinicians, Despite Gains: AHA

Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions

SAFE-PAD Throws More Doubt on the Paclitaxel Mortality Signal

Critical Limb Ischemia During COVID: Lessons for Care and Clinical Trials

AHA Seeks to Drive Down Amputations 20% by 2030

Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval

No Paclitaxel Death Signal in VA Data Out to 3 Years

The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations

‘Frailty Meter’ May Aid Treatment Decisions in Chronic Limb-Threatening Ischemia

BVS Reboot? Signs of Durability to 2 Years in Critical Limb-Threatening Ischemia

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content